We have evaluated the effect of cisapride on interdigestive antroduodenal motility during a prolonged oral therapy in 20 consecutive dyspeptic subjects. Individuals with less than two migrating motor complexes (MMCs) starting from the antral region in 240 minutes and without evidence of upper gastrointestinal tract diseases were randomly treated with either cisapride (10 cases), or placebo (10 cases) for 15 days. Computerised manometry of antroduodenal region was performed for 240 minutes, in basal conditions and on the 15th day of therapy. Symptomatic evaluation of patients was also performed before and after treatment. After cisapride administration, a significant increase in the incidence of antral migrating motor complexes was noticed (p= 0.022); likewise, the motility index, calculated for phase-2 periods, appeared to be significantly higher both in the antrum and in the duodenum (p<0-001).
In recent years, motor disorders of the antroduodenal region have been reported among the main factors involved in pathogenesis of dyspeptic syndrome."
Previous manometric recording of antroduodenal motor activity' and isotopic techniques' 6 showed that delayed gastric emptying and duodenogastric biliary reflux are the most common disorders associated with various and persistent conditions of discomfort of the upper digestive tract, in the absence of organic diseases, that represent the socalled 'functional dyspepsia'.
The prevalence of this common but ill understood entity has been calculated by Krag' to be 27% in western populations. Antroduodenal motor disorders -and specifically the delayed gastric emptying -have formed the basis for the use of several prokinetic drugs, stimulating gastroduodenal motor activity, in the treatment of functional, non-ulcer dyspepsia.
Cisapride, a new prokinetic drug devoid of antidopaminergic and direct cholinergic effect, has been recently reported to activate the migrating motor complex (MMC) in the fasting state9 and to accelerate gastric emptying'0"I after iv administration, both in animals and man, as well as to significantly improve dyspeptic symptoms'2 and gastric emptying'3 during oral chronic treatment.
At present, however, only few and noncontrolled data are available as to the effectiveness of prolonged oral administration of the drug on the patterns of the antroduodenal interdigestive motility cycle (IDMC). '4 The aim of this study was, therefore, to assess the effect of prolonged oral treatment with cisapride on the interdigestive motility in patients suffering from persistent dyspeptic symptoms associated with documented motor abnormalities of the antroduodenal region and without evidence of upper gastrointestinal tract organic diseases.
Methods

SUBJECTS
Twenty consecutive dyspeptic patients, nine men and 11 women, aged between 22 After drugs affecting gastrointestinal motility and gastric secretion had been withdrawn for at least seven days, all patients underwent computerised manometric recording of the antroduodenal region. After an overnight fast, a five lumen polyvinyl chloride probe (external diameter, 0-5 cm) with five side holes spaced 5 cm apart and surface radiopaque markers located in the middle between the third and the fourth hole, was positioned under fluoroscopic control in the proximal part of the duodenum, by locating the radiopaque markers across the pyloric junction. The three upper recording holes were placed in the distal stomach (12-5, 7 5 and 2 5 cm before the pylorus) and the two distal holes in the proximal duodenum (2 5 and 7 5 cm after the pyloric ring). The probe position was also verified fluoroscopically at the end of the examination.
The recording catheters were perfused with distilled water, using a pneumohydraulic low compliance pump, and were connected by five Statham P23 ID transducers to a six channel polygraph (OTE Biomedica). Perfusion pressure was 50 kilopascal (375 mmHg) and perfusion rate was 0 5 ml/min. Respiratory excursions were monitored by means of a strain gauge pneumograph fitted around the patients' abdomen. Manometric data were collected and stored on disks for later analysis, by software developed in our centre. Recording of interdigestive motor activity was prolonged over 240 minutes, as suggested by other authors.6 17 According to previous reports,'5 18-20 the three different phases of each interdigestive motility cycle (IDMC) were visually identified: phase 1 characterised by motor quiescence, phase 2 by irregular motor activity, and phase 3, -that is, the migrating motor complex -by a short burst of rhythmic contractions (activity front).
The following determinants of the interdigestive motility cycle (IDMC) were evaluated: number and site of onset of migrating motor complexes (MMCs); duration of the IDMC; duration of each phase of the IDMC over the recording period. With regard to phase-2 periods, number and amplitude of phasic contractions were also determined, not including waves <8 mmHg to avoid erroneous evaluation of respiratory excursions. A motility index was also calculated, for each sequential 10 minute period and for each of the five recording channels, as number of waves x sum of amplitudes, according to the method described by Malagelada and Stanghellini.4 The values thus computed were cumulated over time to obtain a phase-2 motility index per hour. Finally, phase-2 tracings were analysed for propagated motor waves -that is, contractions migrating aborally at 1-3 cm/sec and recorded consecutively at all the five recording channels.
SYMPTOM SCORING
The following nine symptoms, heartburn, regurgitation, belching, nausea, vomiting, postprandial fullness, postprandial drowsiness, epigastric pain, and bloating were recorded with regard to frequency (0=symptom absence; 1 = one to three episodes/week; 2 =four to seven episodes/week; 3 =more than seven episodes week) and severity (1 =mild; 2=moderate; 3= severe); the evaluation of symptom severity was formulated by the patients themselves, to avoid observer bias. Only subjects presenting at least three symptoms for over six months underwent manometric recording of interdigestive antroduodenal motility, in order to be included in the study. Number and amplitude of phase-2 contractions and phase-2 motility index were evaluated by comparing the cumulated values of the three antral and of the two duodenal recording channels. The results (Table II) show in the cisapride treated patients a highly significant increase (p<0001) of phase-2 motor waves frequency both in the antrum and in the duodenum; moreover, in the antral region a higher frequency correlated with a corresponding increased amplitude of phasic contractions (p=0-001).
As summarised in Figures 2 and 3 , both antral and duodenal phase-2 motility index values (p<0 001) as well as the number of propagated waves per hour (p=0 005) also appeared significantly higher after cisapride administration, while they did not differ from baseline values after placebo.
SYMPTOM EVALUATION
In both the groups, no significant variation was detected in the number of symptoms which each patient complained of before and after the treatment. Symptom scores for frequency and severity of all the patients in basal conditions and during the 15 day treatment with oral cisapride or placebo are reported in Table III. In comparison with pretrial values both cisapride and placebo significantly reduced overall symptoms frequency and severity, with cisapride superior to placebo (p=0049) only in improving the severity of dyspeptic symptoms. As to discrete symptoms, no important variation was noticed in the two groups. No side effects were reported by the patients or detected by the physicians. Finally, no differences were observed between the two groups of treatment regarding magnesium and aluminium antacids consumption. Discussion Functional dyspepsia is a common event characterised by persistent or episodic sympLoms The improvement of the antroduodenal coordination, expressed by the increase of propagated waves, and the higher pressure activity recorded in the antrum but not in the duodenum, could be responsible for the acceleration of gastric emptying as pointed out by other authors,'' " 3 after cisapride administration.
Further investigation would be probably required to verify these findings during the postprandial period also, by means of a 24 hour computerised manometric recording, thus comparing manometric and isotopic results. 
